Clinical trial reportAmerican journal of hematologyPublished
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial
Regional connection
Verified An author affiliation on the Europe PMC record names Pennsylvania Hospital, with Penn Medicine linked by the institution reference. Affiliation source
- Institutions
- Penn Medicine, Pennsylvania Hospital
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- American journal of hematology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Myelodysplastic Syndromes; Isoquinolines; Glycine; Treatment Outcome; Erythrocyte Transfusion; Double-Blind Method; Adult; Aged; Aged, 80 and over; Middle Aged; Female
- PubMed ID
- 38884137
- Open access
- Yes, open
- Added to directory
- Source checked